• OPEN AN ACCOUNT
Indian Indices
Sensex
77,348.38 -20.73
( -0.03%)
Global Indices
Nasdaq
53,439.07 141.06
(0.26%)
Dow Jones
7,673.94 -21.43
(-0.28%)
Hang Seng
65,516.02 -500.34
(-0.76%)
Nikkei 225
10,857.89 41.33
(0.38%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3529756
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
40.85
3385.04
EPS(TTM)
Face Value()
Div & Yield %
7.4
2
1.77
 

Emerald Finance consolidated net profit rises 58.20% in the March 2026 quarter
May 28,2026
Net profit of Emerald Finance rose 58.20% to Rs 4.05 crore in the quarter ended March 2026 as against Rs 2.56 crore during the previous quarter ended March 2025. Sales rose 51.16% to Rs 9.75 crore in the quarter ended March 2026 as against Rs 6.45 crore during the previous quarter ended March 2025.

For the full year,net profit rose 71.65% to Rs 14.47 crore in the year ended March 2026 as against Rs 8.43 crore during the previous year ended March 2025. Sales rose 44.51% to Rs 31.17 crore in the year ended March 2026 as against Rs 21.57 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales9.756.45 51 31.1721.57 45
OPM %69.9567.75 -74.4068.94 -
PBDT6.113.68 66 20.5312.02 71
PBT5.943.60 65 20.3711.94 71
NP4.052.56 58 14.478.43 72